Betulinic Acid Market Size, Share & Trends Analysis Report By Type (Natural Betulinic Acid, Synthetic Betulinic Acid), By Application (Pharmaceutical Applications, Cosmetics Applications) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Ismail Sutaria | Format:

Betulinic Acid Market Size

The global betulinic acid market size was valued at USD 2.5 billion in 2025 and is projected to grow from USD 2.69 billion in 2026 to USD 4.75 billion by 2034, registering a CAGR of 7.4% during the forecast period from 2026 to 2034. North America dominated the betulinic acid market with a market share of 35% in 2025.

Market Key Takeaways

Global Market Size & Growth

North America dominated the market with the largest share of 35% in 2025.
Asia Pacific is expected to be the fastest-growing region during the forecast period, registering a CAGR of 7.8%.
By type, the natural betulinic acid dominated the market with a 57.2% revenue share in 2025.
By application, the pharmaceutical segment held the largest share of 55% in 2025.
The US betulinic acid market size was valued at USD 0.95 billion in 2025 and is projected to be USD 1.5 billion in 2026.
Betulinic Acid Market Size

Download a Free Sample To learn more about this report.

Type Insights

The natural betulinic acid segment accounted for the largest market share in 2025. Strong consumer preference for plant-derived compounds and sustainability aligns well with natural, clean-label, and sustainable ingredients. Natural betulinic acid is widely used in cosmetics, nutraceuticals, and pharmaceutical applications as a safer and more environmentally friendly alternative.

The synthetic betulinic acid segment is expected to grow at a CAGR of 10% during the forecast period. The growth is driven by drug development activities and rising pharmaceutical research. This acid is used in clinical research and advanced medical applications due to its purity, consistent quality, and scalability features.

Betulinic Acid Market Size By Segments

Request Customizationto receive a tailored report.

Application Insights

The pharmaceutical applications segment holds the largest market share, accounting for 55% of total revenue in 2025. This segment is driven by extensive use of betulinic acid in drug development for anti-cancer, anti-inflammatory, and anti-viral properties. It can target diseased cells and comparatively cause less damage to healthy cells. Bioactive properties are highly valued by companies and researchers. Ongoing clinical research and studies further strengthen the role of betulinic acid in the pharmaceutical sector.

The cosmetics application segment is projected to grow at a CAGR of 7.5% during the forecast period. Natural active ingredients are incorporated into anti-aging, skin-smoothing, and repair-focused skincare products due to increasing inclination toward looking more youthful. With consumers becoming more selective, their awareness of clean-label ingredients is also increasing. Thus, the boost to the cosmetics industry is expected to propel market growth during the forecast period.

Betulinic Acid Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

The betulinic acid market in North America had a market share of 35% in 2025. The growth is driven by strong pharmaceutical R&D capabilities and well-established cosmetics and nutraceutical industries. With increasing investments in cancer research focused on curbing tumor growth, triggering cancer cell death, and reducing metastasis, the region boasts of robust medical infrastructure. The American Cancer Society awarded 92 research grants in 2025, totaling USD 43.2 million. The region also has highly developed cosmetics and neurological industries, with a strong consumer preference for natural, plant-based ingredients.

The US is the fastest-growing country in North America, growing at a CAGR of 6.9% during the forecast period. US companies and research labs are actively focusing on advanced delivery systems such as nanoparticles and liposomes to overcome solubility and bioavailability limitations. Clear regulatory pathways for dietary supplements, cosmetic ingredients, and early-stage drug research make the US an attractive market for scaling and making betulinic acid-based products.

North America Betulinic Acid Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe

Europe held around 25% of the market share in 2025. Betulinic acid aligns well with European market preferences due to its plant-derived origin and multifunctional bioactivity. The region has a strict regulatory framework, such as REACH, which requires detailed chemical characterization, safety testing, and traceability. The legislation encourages the manufacturers to produce high-purity, well-characterized bioactive ingredients. European companies heavily focus on innovation, bioavailability, and product combinations.

Germany is expected to have considerable growth in the European region with a CAGR of 6.3%. German consumers are highly conscious and prefer plant-based and clinically supported ingredients. There are companies in Germany, such as Dermapharm AG, which emphasize innovation and R&D in natural and multifunctional formulants. Certification and labeling standards such as Cosmetic Organic and Natural Standard (COSMOS) help verify that the products are truly natural or organic and build consumer trust.

Asia Pacific

Asia Pacific accounted for 20% of the market share in 2025, owing to large-scale extraction and manufacturing facilities to produce high-purity bioactive compounds. The personal care industry in the Asia Pacific is currently growing rapidly, as consumers prefer plant-based, multifunctional, and safe ingredients. Developing countries in this region are also exhibiting initiatives to integrate modern products in treatments. For instance, the Ayush Promotion Policy by the Government of India aims to integrate traditional medicines with modern wellness products.

China is expected to grow at a CAGR of 7.2% during the forecast period. China combines traditional medicines with modern nutraceutical and pharmaceutical R&D. It is also investing in pharmaceutical and bioactive research. For instance, a December 2025 study revealed co-delivery systems with betulinic acid for cancer immunotherapy. The country also has ample raw materials to scale up production due to the presence of birch-producing areas, such as Northeast China. These factors make China a leading country in the Asia Pacific market.

Latin America

Latin America held 15% of the global market share in 2025. The region has rich biodiversity and plant-based raw materials, which makes it suitable for extracting bioactive compounds. The availability of raw materials enables both local production and export, lowering costs and market growth. Consumers have also started showing interest in herbal supplements, which encourages companies to incorporate bioactive compounds.

Brazil is experiencing considerable growth in the Latin American region, with a CAGR of 6.8% during the forecast period. Brazil provides many sources of plant compounds due to an abundance of natural resources. The Brazilian Health Regulatory Agency plays a vital role in the regulatory framework for herbal supplements and cosmetic products. The country has a growing focus on bioactive therapeutic research, an established natural product industry, and a growing trend toward functional health ingredients.

Middle East & Africa

The Middle East & Africa region accounted for 5% of market share in 2025. The region heavily relies on imports of premium nutraceuticals and cosmetic products from Europe, North America, and Asia Pacific. The imports often feature bioactive ingredients, helping to introduce and expand their market presence.

South Africa is the fastest-growing country in the Middle East & Africa region, with a CAGR of 6.5% during the forecast period. South Africa has a diverse flora, which makes it suitable for extracting natural bioactive. In 2025, South Africa launched a National Action Plan (NAP) to prevent substandard and fake medical products by monitoring supply chain and traceability across health sectors.

Competitive Landscape

The betulinic acid market is moderately fragmented with competition among multinational cosmetic and pharmaceutical corporations, regional extraction manufacturers, nutraceutical firms, and private firm suppliers. The regional manufacturers compete on cost and locally sourced formulations. The intensity of competition in this market is based on a combination of factors such as product innovation, bioactive quality, and regulatory compliance. Emerging trends in this market include rising investment in anti-inflammatory and anti-tumor properties and the incorporation of betulinic acid in nutraceuticals and cosmeceuticals.

List of Key and Emerging Players in Betulinic Acid Market

Manus Aktteva Biopharma LLP Aktin Chemicals Inc. Capot Chemical Co. Ltd.
Tokyo Chemical Industry Co. Ltd.
Cayman Chemical
Toronto Research Chemicals
Glentham Life Sciences
Bionov
Symrise BioActives GmbH
Croda International Plc
Alba Volka Group
Adooq Bioscience
Huanwei Biotech
Vytrus Biotech
Hunan Nutramax Inc.
Shaanxi Pioneer Biotech
BioVision Inc.
Plamed Green Science Group
Tianjin NWS
Kono Chem Co. Ltd.
Greenleaf

Key Industry Developments

June 2026
Merck expanded its specialty chemical and research ingredient portfolio by introducing advanced betulinic acid solutions featuring improved purity, quality standards, and research-grade applications. The company focused on supporting pharmaceutical, biotechnology, and academic research activities involving natural bioactive compounds.
April 2026
Cayman Chemical expanded its bioactive compound portfolio by strengthening its betulinic acid product offerings for scientific research, drug discovery, and biochemical studies. The company focused on providing high-quality analytical and research materials for pharmaceutical applications.
January 2026
Selleck Chemicals expanded its natural compound research portfolio by developing enhanced betulinic acid products designed for oncology research, molecular studies, and therapeutic discovery applications.
October 2025
TCI Chemicals expanded its specialty reagent portfolio by introducing improved betulinic acid formulations with enhanced purity and consistency for laboratory research and pharmaceutical development applications.

Report Scope

Segmentation

By Type 2
  • Natural Betulinic Acid
  • Synthetic Betulinic Acid
By Application 2
  • Pharmaceutical Applications
  • Cosmetics Applications

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Manus Aktteva Biopharma LLP · Aktin Chemicals Inc. · Capot Chemical Co. Ltd. · Tokyo Chemical Industry Co. Ltd. · Cayman Chemical
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The betulinic acid market size is valued at USD 2.69 Billion in 2026 and is projected to reach USD 4.75 Billion by 2034, at a CAGR of 7.4% during the forecast period 2026-2034.

North America dominated the market with a share of 35% in 2025.

The leading companies in this market are Manus Aktteva Biopharma LLP, Aktin Chemicals Inc., Capot Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Cayman Chemical.

The betulinic acid market is projected to grow at a CAGR of 7.4% during the forecast period of 2026 2034.
About the Author
Ismail Sutaria
Ismail Sutaria
Research Head

Ismail Sutaria is a market intelligence and strategy professional with over 12 years of experience advising organizations across the chemicals, packaging, industrial machinery, and energy & power sectors. He specializes in delivering data-driven market assessments, commercial due diligence, industry benchmarking, demand forecasting, competitive strategy, and growth advisory that enable businesses to make confident investment and expansion decisions in complex industrial markets.

His expertise spans specialty and commodity chemicals, advanced and sustainable packaging solutions, industrial automation, manufacturing equipment, process engineering, renewable energy, conventional power generation, electrical infrastructure, and industrial technologies. Ismail has developed deep domain knowledge in evaluating market ecosystems, technology evolution, regulatory frameworks, supply-demand dynamics, pricing trends, value chain structures, and competitive landscapes across global and regional markets.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: